NewsEarningsPrism Medico & Pharmacy Limited Reports Remarkable Q1 Performance with ₹65.73 Lakh Net ProfitPrism Medico & Pharmacy Limited Reports Remarkable Q1 Performance with ₹65.73 Lakh Net Profit
Prism Medico & Pharmacy Limited announced a significant financial turnaround in Q1. Revenue from operations increased to ₹158.87 lakhs from ₹7.28 lakhs in the previous quarter. Net profit reached ₹65.73 lakhs, compared to ₹4.15 lakhs in Q4 and a loss of ₹9.00 lakhs year-over-year. The company demonstrated improved operational efficiency and cost management despite the revenue surge. The Board of Directors approved these unaudited standalone financial results, which were reviewed by auditors and submitted to stock exchanges in compliance with SEBI regulations.
*this image is generated using AI for illustrative purposes only.
Prism Medico & Pharmacy Limited has reported a significant turnaround in its financial performance for the first quarter. The company's Board of Directors approved the unaudited standalone financial results, showcasing substantial growth in revenue and profitability.
Financial Highlights
Revenue Surge: The company's revenue from operations skyrocketed to ₹158.87 lakhs, marking a remarkable increase from ₹7.28 lakhs in the previous quarter and ₹6.27 lakhs in the corresponding quarter last year.
Profit Boost: Net profit for the quarter reached ₹65.73 lakhs, compared to ₹4.15 lakhs in the previous quarter and a loss of ₹9.00 lakhs in the year-ago period.
Earnings Per Share: The company's earnings per share improved to ₹0.01 from ₹0.00 in the previous quarter.
Quarterly Performance Overview
| Particulars (in Lakhs) | Q1 | Q4 | Q1 (Previous Year) |
|---|---|---|---|
| Revenue from Operations | 158.87 | 7.28 | 6.27 |
| Total Income | 158.91 | 8.37 | 6.48 |
| Total Expenses | 93.84 | 6.11 | 15.42 |
| Net Profit/(Loss) | 65.73 | 4.15 | (9.00) |
Key Observations
Cost Management: Despite the significant increase in revenue, the company managed to keep its expenses under control. Total expenses for the quarter were ₹93.84 lakhs, with the cost of materials consumed being the largest component at ₹85.75 lakhs.
Operational Efficiency: The company demonstrated improved operational efficiency, turning a loss-making position from the previous year into a profitable one.
Capital Structure: The paid-up equity share capital remained stable at ₹606.34 lakhs.
Management Commentary
The financial results were reviewed by auditors Garg Mendiratta & Associates and approved by the Board. The company's management expressed satisfaction with the strong quarterly performance, highlighting the significant improvement in both top-line and bottom-line figures.
Regulatory Compliance
In compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Prism Medico & Pharmacy Limited has submitted these results to the stock exchanges. The limited review report by the auditors stated that nothing has come to their attention that causes them to believe that the financial results do not present a true and fair view in accordance with applicable accounting standards.
Investors and stakeholders will be keenly watching to see if Prism Medico & Pharmacy Limited can maintain this growth trajectory in the coming quarters.
Historical Stock Returns for Prism Medico & Pharmacy
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.97% | -0.40% | +22.68% | +21.05% | -38.11% | +8.32% |
16
